Immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: A single-center experience.

Kaur, Aneet; Doberstein, Taylor; Amberker, Rachana Ramesh; Garje, Rohan; Field, Elizabeth Hirak; Singh, Namrata

Kaur, Aneet; Doberstein, Taylor; Amberker, Rachana Ramesh; Garje, Rohan; Field, Elizabeth Hirak; Singh, Namrata.

Affiliation

Kaur A; Division of Immunology, University of Iowa Hospitals and Clinics, Iowa City, IA.
Doberstein T; ThedaCare Orthopedic Care-Rheumatology, Neenah, Wisconsin.
Amberker RR; St Joseph Mercy Hospital, Ann Arbor, MI.
Garje R; University of Iowa Hospitals and Clinics.
Field EH; Division of Immunology, University of Iowa and Clinics and Iowa City VA Medical Center.
Singh N; Division of Immunology, University of Iowa Hospitals and Clinics and Iowa City VA Medical Center, Iowa City, IA.

Medicine (Baltimore) ; 98(41): e17348, 2019 Oct.

Article in En | MEDLINE | ID: mdl-31593084

Subject(s)

Antineoplastic Agents, Immunological/adverse effects; Immune System Diseases/chemically induced; Immunotherapy/adverse effects; Melanoma/drug therapy; Neoplasms/drug therapy; Adult; Aged; Aged, 80 and over; Autoimmune Diseases/chemically induced; Autoimmune Diseases/immunology; CTLA-4 Antigen/antagonists & inhibitors; Female; Humans; Immune System Diseases/immunology; Male; Melanoma/immunology; Middle Aged; Neoplasms/immunology; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Immune System Diseases / Immunotherapy / Melanoma / Neoplasms Type of study: Evaluation_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2019 Document type: Article

Fulltext

XML

PubMed Links

Search on Google